Renal lesions in HIV-1-positive patient treated with tenofovir [3]

AIDS

Volumn 17, Issue 6, 2003, Pages 935-937

  Créput, Caroline ^a   Gonzalez Canali, Gustavo ^a   Hill, Gary ^a   Piketty, Christophe ^a,b   Kazatchkine, Michel ^a,b   Nochy, Dominique ^a  

^a Hôp Europ Georges Pompidou ^*  (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; DIDANOSINE; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE; TENOFOVIR DISOPROXIL; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; CASE REPORT; DRUG WITHDRAWAL; FANCONI RENOTUBULAR SYNDROME; FEVER; GLUCOSURIA; HEMATURIA; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMEROSCAPULAR PERIARTHRITIS; HYPERTENSION; HYPOURICEMIA; INTERSTITIAL LUNG DISEASE; LETTER; LIPOATROPHY; MALE; METABOLIC ACIDOSIS; NEPHRITIS; PHOSPHATURIA; PRIORITY JOURNAL; PROTEINURIA;

ADENINE; ANTI-HIV AGENTS; FANCONI SYNDROME; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS;

EID: 0038301428     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200304110-00026     Document Type: Letter

References (4)

1. Schooley RT, Ruane P, Myers RA, Beall G, Lampiris H, Berger D, et al. Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomised, double-blind study. AIDS 2002, 16:1257-1263.
2. Meier P, Dautheville-Guibal S, Ronco P, Rossert J. Cidofovir-induced end-stage renal failure. Nephrol Dial Transplant 2002, 17:148-149.
3. Cihlar T, Ho E, Lin D, Mulato A. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucl Acids 2001, 20:641-648.
4. Dobkin JF. Tenofovir: the first nucleotide for HIV infection. Infect Med 2002, 19:11.